Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat Patients with MASH in Phase IIb Study

Business Wire

RAMAT GAN, Israel, May 9, 2024–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a portfolio of proprietary small molecule drugs that treat oncology and inflammatory diseases, …

Read more

Palatin Announces FDA Clearance of IND Application for Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity

PR Newswire

Phase 2 The clinical study is expected to begin in mid-2024 Organization of KOL virtual event “Beyond GLPs”. May 8, 2024 CRANBURY, NJ, May 2, 2024 /PRNewswire/ — Palatin Technologies, …

Read more